Atish Choudhury, MD PhD(@AtishChoudhury) 's Twitter Profile Photo

Don’t miss my lecture during the PER symposium on maximizing PARP inhibitors in patients with CRPC at the annual oncology meeting in Chicago on June 4! Sign up today! bit.ly/3MPI5e6

Don’t miss my lecture during the PER symposium on maximizing PARP inhibitors in patients with CRPC at the annual oncology meeting in Chicago on June 4! Sign up today! bit.ly/3MPI5e6 #GUcancer #gotoPER
account_circle
Sharyn Foster(@SharynMFoster) 's Twitter Profile Photo

This Group of experts from @miamicancerinst Kristen Millado Bruno Bastos MD Antonio Muina & Maria Carla Dominguez got together OncLive SOSS to discuss metastatic RCC, UC & PARP Inhibitors in . Superb presentations by all.

This Group of experts from @miamicancerinst @KMilladoMD  @BrunoBastosMD Antonio Muina & Maria Carla Dominguez got together @OncLiveSOSS to discuss metastatic RCC, UC #GUCancer & PARP Inhibitors in #prostatecancer. Superb presentations by all.
account_circle
European Urology Oncology(@EurUrolOncol) 's Twitter Profile Photo

This month’s European Urology Oncology Award is presented to…

🟠Intermediate-risk NMIBC: Updated Consensus Definition and Management Recommendations from the IBCG🟠

Congrats to Wei Shen Tan and the powerful armada!

This month’s @EurUrolOncol #SoMe Award is presented to…

🟠Intermediate-risk NMIBC: Updated Consensus Definition and Management Recommendations from the @IBCG_BladderCA🟠

Congrats to @drtanws and the powerful #bladdercancer armada!

#UroSoMe #GUcancer #uroonc
account_circle
European Urology Oncology(@EurUrolOncol) 's Twitter Profile Photo

The latest European Urology Oncology issue is out!

euoncology.europeanurology.com/current

Featuring:
🟢Triplet therapy in mHSPC
🔴Update on intermediate-risk NMIBC
🔵Consensus in
🟠QoL in CM-274

Happy reading!

The latest @EurUrolOncol issue is out!

euoncology.europeanurology.com/current 

Featuring:
🟢Triplet therapy in mHSPC
🔴Update on intermediate-risk NMIBC
🔵Consensus #PSMA #PET in #prostatecancer
🟠QoL #nivolumab in CM-274 #bladdercancer

Happy reading! #GUcancer #UroSoMe
account_circle
European Association of Urology (EAU)(@Uroweb) 's Twitter Profile Photo

Incorporating the patient’s voice is a vital step to . The provide multidisciplinary, evidence-based recommendations for patients.

uroweb.org/individual-gui…

Incorporating the patient’s voice is a vital step to #ClosetheCareGap. The #EAUGuidelines provide multidisciplinary, evidence-based recommendations for #GUcancer patients. #wcd22 #WorldCancerDay

uroweb.org/individual-gui…
account_circle
Elsevier Urology(@Els_Urology) 's Twitter Profile Photo

New to the @uroweb family of journals: European Urology Oncology, accepting papers on GU cancers. Watch the full introduction by Editor-in-Chief Alberto Briganti here: bit.ly/2MIbz04 European Urology Oncology @EUPlatinum

account_circle
ACS Journal Cancer(@JournalCancer) 's Twitter Profile Photo

Read our Sept 1 issue! 📗

🔗acsjournals.onlinelibrary.wiley.com/toc/10970142/2…

In this issue:
➡️ top advances by Tom Powles drfrankiejs Christopher Sweeney, MBBS
➡️ Editorial by A. Emre Eşkazan, MD 🩸🔬 on frontline TKI therapy in chronic-phase CML
➡️ Highs and lows of serous by Beryl Manning-Geist, MD et al

account_circle
BMUC(@bmuc_be) 's Twitter Profile Photo

Interested in lectures and discussions on different treatments by (inter)national experts (such as Shankar Siva, Daniel E Spratt, Anwar Padhani)? You can now register on bmuc.be/bmuc2021/regis…

Interested in lectures and discussions on different #GUcancer treatments by (inter)national experts (such as @_ShankarSiva, @DrSpratticus, @ProfPadhani)? You can now register on bmuc.be/bmuc2021/regis…
account_circle
European Association of Urology (EAU)(@Uroweb) 's Twitter Profile Photo

✍️ Read today's report from the Plenary: Controversies in staging: Is it only imaging? Highlights: Molecular imaging, biomarkers, PSMA M1a positive patient, PSMA PET standardisation, & the ‘Oncidium Initiative’

👉eaucongress.uroweb.org/plenary-sessio…

#EAU24 ✍️ Read today's report from the Plenary: Controversies in #GUCancer staging: Is it only imaging? Highlights: Molecular imaging, biomarkers, PSMA M1a positive patient, PSMA PET standardisation, & the ‘Oncidium Initiative’ #Radiotheranostics 

👉eaucongress.uroweb.org/plenary-sessio…
account_circle